Pegasys (peginterferon alfa-2a) 180 micrograms/0.5 mL pre-filled syringes, pack of 4 — Austria Chronic hepatitis C Targeted cancer therapy. Drug delivery from Europe and beyond, within 4-5 days, with strict storage conditions. +380996042415, Viber, WhatsApp.

Chronic Hepatitis C

 Adult Patients

 Pegasys® in combination with other medicinal products is indicated for the treatment of chronic hepatitis C (CHC) in patients with compensated liver disease.

 Children 5 years of age and older

 In combination with ribavirin for the treatment of chronic hepatitis C in previously untreated children and adolescents 5 years of age and older with a positive serum test for hepatitis C virus RNA (HCV).

 Chronic Hepatitis B

 Adult Patients

 Treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B (CHB) in adult patients with compensated liver disease and evidence of viral replication, elevated alanine aminotransferase (ALT) levels and histologically confirmed liver inflammation and/or FIB

Children 3 years and older

Treatment of HBeAg-positive CHB in children and adolescents 3 years and older without cirrhosis, with evidence of viral replication and persistently elevated serum ALT levels. For decision-making on initiating treatment in children